A Randomized, Open-Label Study of the Effect of PEGASYS Plus COPEGUS With or Without Concomitant Pioglitazone (Actos) on Early Viral Kinetics in Treatment-Naive Patients With Chronic Hepatitis C, Genotype-1, and Insulin Resistance.
Phase of Trial: Phase IV
Latest Information Update: 04 May 2012
At a glance
- Drugs Peginterferon alfa-2a; Pioglitazone; Ribavirin
- Indications Hepatitis C; Insulin resistance
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 11 Jul 2011 NCT reports actual patient number as 154.
- 15 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History